All Relations between Haloperidol and dopamine

Publication Sentence Publish Date Extraction Date Species
P J Wellma. The pharmacology of the anorexic effect of phenylpropanolamine. Drugs under experimental and clinical research. vol 16. issue 9. 1991-08-19. PMID:2100250. pharmacological blockade of dopamine receptors, using haloperidol, reduces amphetamine anorexia but is without effect on ppa anorexia. 1991-08-19 2023-08-11 Not clear
R J Croughs, J H Thijssen, J A Mo. Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease. Journal of endocrinological investigation. vol 14. issue 3. 1991-08-16. PMID:1649212. no alpha-msh could be detected in plasma of normal subjects (n = 6), in plasma of patients with addison's disease (n = 3), nelson's syndrome (n = 2), bromocriptine responsive (n = 2) and unresponsive (n = 5) cushing's disease and in plasma of psychiatric patients on chronic treatment with the dopamine antagonist haloperidol (n = 5). 1991-08-16 2023-08-11 human
C L Duvauchelle, A Ettenber. Haloperidol attenuates conditioned place preferences produced by electrical stimulation of the medial prefrontal cortex. Pharmacology, biochemistry, and behavior. vol 38. issue 3. 1991-08-13. PMID:2068202. pretreatment with the neuroleptic dopamine antagonist drug, haloperidol (0.0, 0.15, or 0.3 mg/kg ip), resulted in a dose-dependent reduction in the magnitude of observed place preferences. 1991-08-13 2023-08-11 human
M H Schmidt, T Le. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure. Psychiatry research. vol 36. issue 3. 1991-08-08. PMID:1676523. to test the hypothesis that neuroleptic blockade impairs the development of striatal dopamine d2 receptors, pregnant rats were given haloperidol, thiothixene, or trifluoperazine for gestational days 15-18 (short-term exposure) or days 5-20 (long-term exposure). 1991-08-08 2023-08-11 rat
M Bregni, S Siena, M Di Nicola, G Bonadonna, A M Giann. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. European journal of cancer (Oxford, England : 1990). vol 27. issue 5. 1991-08-01. PMID:1828962. in a second group of 26 consecutive patients, a combination of tropisetron plus haloperidol, a dopamine antagonist, was employed for prevention of emesis. 1991-08-01 2023-08-11 Not clear
K Kurata, R Shibat. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. Pharmacology. vol 42. issue 1. 1991-08-01. PMID:2057516. differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. 1991-08-01 2023-08-11 rat
K Kurata, R Shibat. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. Pharmacology. vol 42. issue 1. 1991-08-01. PMID:2057516. the differential effects of haloperidol on dopamine release and its metabolism were investigated in the anteromedial frontal cortex and the caudate putamen using the intracerebral dialysis method in anesthetized rats after single intraperitoneal injections of 0.01, 0.125 and 2 mg/kg haloperidol. 1991-08-01 2023-08-11 rat
K Kurata, R Shibat. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. Pharmacology. vol 42. issue 1. 1991-08-01. PMID:2057516. there was a clear difference in the time-response curve of dopamine release between the two brain regions after the injection of 0.125 mg/kg haloperidol, but no difference after the administration of the other doses. 1991-08-01 2023-08-11 rat
B Dean, P Srikanthan, D L Copolo. Inhibition of [3H]dopamine uptake by platelets by the dopamine-D2 receptor agonist RU 24926. The Journal of pharmacy and pharmacology. vol 43. issue 1. 1991-07-31. PMID:1676063. ru 24926 reduced the uptake of [3h]dopamine by platelet-rich plasma and this affect was not reversed by the dopamine-d2 receptor antagonist haloperidol, or the dopamine-d1 receptor antagonist sch 23390 (8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1h-3-benzazepine-7-ol). 1991-07-31 2023-08-11 human
C S Tung, J Grenhoff, T H Svensso. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo. Journal of neural transmission. General section. vol 84. issue 1-2. 1991-07-29. PMID:2054150. kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo. 1991-07-29 2023-08-11 rat
C S Tung, J Grenhoff, T H Svensso. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo. Journal of neural transmission. General section. vol 84. issue 1-2. 1991-07-29. PMID:2054150. the acute effect of systemic administration of the antipsychotic drug haloperidol on the activity of midbrain dopamine (da) neurons was investigated with extracellular single cell recording in the chloral hydrate anaesthetized male rat. 1991-07-29 2023-08-11 rat
Y Chugh, N Saha, A Sankaranarayanan, P L Sharm. Possible mechanism of haloperidol-induced enhancement of memory retrieval. Methods and findings in experimental and clinical pharmacology. vol 13. issue 3. 1991-07-25. PMID:2051840. this effect of haloperidol is possibly mediated by interaction with alpha 2-adrenergic receptors, that results in increasing the noradrenergic transmission, or it could be due to direct interaction with dopamine receptors. 1991-07-25 2023-08-11 Not clear
R D Kirkby, L Kokkinidi. Amphetamine sensitization and amygdala kindling: pharmacological evaluation of catecholaminergic and cholinergic mechanisms. Brain research bulletin. vol 26. issue 3. 1991-07-23. PMID:1646666. haloperidol (hal) treatment failed to block the stimulant-induced increase in kindling acquisition indicating that changes in dopamine (da) are not necessary for the amph/kindling synergism to develop. 1991-07-23 2023-08-11 human
M H Tai, K L Teo, J T Pa. Serotonin-stimulated prolactin secretion may not involve the dopaminergic system. The Chinese journal of physiology. vol 33. issue 4. 1991-07-23. PMID:2097103. they either received pretreatment with alpha-methyl-p-tyrosine (250 mg/kg bw, ip), a dopamine (da) synthesis inhibitor, or two da antagonists, domperidone and haloperidol (0.1 mg/kg bw, iv) before receiving 5-ht (1 mg/kg bw, iv) or quipazine (1 mg/kg bw, iv), a 5-ht agonist. 1991-07-23 2023-08-11 rat
L Hernandez, T Baptista, B G Hoebe. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats. Progress in neuro-psychopharmacology & biological psychiatry. vol 14 Suppl. 1991-07-23. PMID:2097671. chronic administration of haloperidol decreased dopamine turnover in the prefrontal cortex and the striatum. 1991-07-23 2023-08-11 rat
L Hernandez, T Baptista, B G Hoebe. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats. Progress in neuro-psychopharmacology & biological psychiatry. vol 14 Suppl. 1991-07-23. PMID:2097671. the antipsychotic effect of haloperidol might be related to dopamine turnover decrease in the prefrontal cortex. 1991-07-23 2023-08-11 rat
B Moghaddam, B S Bunne. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Progress in neuro-psychopharmacology & biological psychiatry. vol 14 Suppl. 1991-07-23. PMID:2097674. in vivo microdialysis was utilized to assess the effect of clozapine, haloperidol, and sulpiride on the release of dopamine from the nucleus accumbens, striatum, and prefrontal cortex of the rat. 1991-07-23 2023-08-11 rat
B Moghaddam, B S Bunne. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Progress in neuro-psychopharmacology & biological psychiatry. vol 14 Suppl. 1991-07-23. PMID:2097674. haloperidol and sulpiride were more effective in releasing dopamine from the terminals of the nigrostriatal dopamine system while clozapine had a more prefrontal effect on the mesolimbic and particularly the mesocortical dopamine systems. 1991-07-23 2023-08-11 rat
A M Evans, K L Gree. The action of dopamine receptor antagonists on the secretory response of the cockroach salivary gland in vitro. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. vol 97. issue 2. 1991-07-18. PMID:1982871. chlorpromazine (0.5-5 microm), sch23390 (10-100 microm), haloperidol (10-100 microm) and metoclopramide (2 mm) competitively inhibited the secretory response to dopamine. 1991-07-18 2023-08-11 Not clear
R Longoni, L Spina, A Mulas, E Carboni, L Garau, P Melchiorri, G Di Chiar. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 11. issue 6. 1991-07-15. PMID:1646295. blockade of dopamine d1 receptors by sch 23390 abolished (d-ala2)deltorphin ii effects, while blockade of dopamine d2 receptors by raclopride or by haloperidol was without effect. 1991-07-15 2023-08-11 rat